SB
EW icon

Suntrust Banks’s Edwards Lifesciences EW Stock Holding History

Suntrust Banks’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$4.5M Buy
61,335
+735
+1% +$51.6K 0.02% 368
2019
Q2 		$3.73M Buy
60,600
+3,297
+6% +$199K 0.02% 412
2019
Q1 		$3.65M Buy
57,303
+5,772
+11% +$329K 0.02% 401
2018
Q4 		$2.63M Buy
51,531
+9,798
+23% +$496K 0.02% 453
2018
Q3 		$2.42M Sell
41,733
-11,415
-21% -$558K 0.01% 501
2018
Q2 		$2.58M Buy
53,148
+5,952
+13% +$278K 0.01% 468
2018
Q1 		$2.19M Buy
47,196
+204
+0.4% +$8.86K 0.01% 499
2017
Q4 		$1.76M Sell
46,992
-3,309
-7% -$121K 0.01% 556
2017
Q3 		$1.83M Sell
50,301
-10,764
-18% -$411K 0.01% 564
2017
Q2 		$2.41M Sell
61,065
-13,179
-18% -$481K 0.01% 456
2017
Q1 		$2.33M Sell
74,244
-2,355
-3% -$73.7K 0.01% 433
2016
Q4 		$2.39M Sell
76,599
-27,198
-26% -$881K 0.01% 500
2016
Q3 		$4.17M Buy
103,797
+8,289
+9% +$312K 0.03% 322
2016
Q2 		$3.17M Sell
95,508
-93
-0.1% -$3.18K 0.02% 378
2016
Q1 		$2.81M Buy
95,601
+37,338
+64% +$1.03M 0.02% 382
2015
Q4 		$1.53M Buy
58,263
+6,747
+13% +$175K 0.01% 536
2015
Q3 		$1.22M Buy
51,516
+40,044
+349% +$967K 0.01% 551
2015
Q2 		$271K Sell
11,472
-276
-2% -$6.23K ﹤0.01% 1054
2015
Q1 		$278K Sell
11,748
-276
-2% -$6.19K ﹤0.01% 1057
2014
Q4 		$254K Sell
12,024
-3,756
-24% -$75.5K ﹤0.01% 1059
2014
Q3 		$268K Buy
15,780
+612
+4% +$9.66K ﹤0.01% 1221
2014
Q2 		$216K Sell
15,168
-8,184
-35% -$111K ﹤0.01% 1331
2014
Q1 		$287K Buy
+23,352
New +$269K ﹤0.01% 1604
2013
Q4 		– Sell
-22,734
Closed -$263K – 1848
2013
Q3 		$263K Sell
22,734
-4,584
-17% -$53.6K ﹤0.01% 1541
2013
Q2 		$305K Buy
+27,318
New +$323K ﹤0.01% 1400

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Suntrust Banks's EW Position: Q3 2019 in Review

Suntrust Banks increased its Edwards Lifesciences (EW) stake by 1.2% in Q3 2019, buying an estimated $51.6K and bringing the position to 61,335 shares worth $4.5M. The position accounts for 0.02% of the portfolio, ranked #368.

Suntrust Banks first reported a position in EW in Q2 2013 and has held it in 25 quarters since. 965 funds tracked by Wall St. Rank hold EW as of Q3 2019.

  • Suntrust Banks held 61,335 shares of Edwards Lifesciences worth $4.5M as of Q3 2019.
  • Suntrust Banks bought 735 Edwards Lifesciences shares in Q3 2019, an estimated $51.6K.
  • Edwards Lifesciences made up 0.02% of Suntrust Banks's portfolio in Q3 2019, its #368 holding.
  • Suntrust Banks first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 25 quarters since.
  • 965 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2019.

Based on Suntrust Banks's 13F filing for Q3 2019, filed 12 Nov 2019.